On Monday, the Food and Drug Administration (FDA) approved and authorized for emergency use updated COVID-19 vaccines that target variants of the virus that are currently circulating. The new monovalent vaccines provide better protection against serious illness, hospitalization and death. As part of the FDA's announcement, the bivalent Moderna and Pfizer-BioNTech COVID-19 vaccines previously approved are no longer authorized for use in the United States. Read more.
The following day, the Centers for Disease Control and Prevention (CDC) issued its recommendation that everyone 6 months and older should get an updated COVID-19 vaccine, which it expects to be available this week. In a press release, the CDC said, "Vaccination remains the best protection against COVID-19-related hospitalization and death. Vaccination also reduces your chance of suffering the effects of Long COVID, which can develop during or following acute infection and last for an extended duration." It also noted that most Americans can receive a COVID-19 vaccine for free. Most private health insurance plans cover the cost of the vaccine, while those with no insurance can get a free vaccine from local health centers, departments of health, or pharmacies that participate in the Bridge Access Program.
First Vaccine Season to Offer Protection Against Three Main Viruses
The CDC noted that this will be the first fall and winter season in which vaccines are available for the three viruses most responsible for hospitalizations - COVID-19, RSV and flu. The CDC has updated its Influenza Communication Resource Center. The site includes the CDC Digital Media Toolkit for the 2023-2024 flu season. With the theme of "Wild to Mild," these materials can help you communicate the importance of vaccination to not only lesson flu complications but decrease possible hospitalizations.
|